Depo-Provera: Bone Mineral Density and Total Body Calcium in Adolescent DP150CI Users and Non-Hormonal Contraception
Public ClinicalTrials.gov record NCT00139685. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.
Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.
Official title
Depo-Provera: Evaluation of Bone Mineral Density and Total Body Calcium in Adolescent DP 150 CI Users and Matched Controls
Study identification
- NCT ID
- NCT00139685
- Recruitment status
- Completed
- Study type
- Interventional
- Phase
- Phase 4
- Lead sponsor
- Pfizer
- Industry
- Enrollment
- 350 participants
Conditions and interventions
Conditions
Interventions
- Depo-Provera Contraceptive Injection - DP150CI Drug
Drug
Eligibility (public fields only)
- Age range
- 12 Years to 18 Years
- Sex
- Female
- Healthy volunteers
- Accepts healthy volunteers
This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.
Study timeline
- Start date
- Mar 31, 1998
- Primary completion
- Jul 31, 2006
- Completion
- Jun 30, 2007
- Last update posted
- Sep 24, 2008
1998 – 2007
United States locations
- U.S. sites
- 12
- U.S. states
- 9
- U.S. cities
- 12
| Facility | City | State | ZIP | Site status |
|---|---|---|---|---|
| Pfizer Investigational Site | Los Angeles | California | — | — |
| Pfizer Investigational Site | Palo Alto | California | — | — |
| Pfizer Investigational Site | Torrance | California | — | — |
| Pfizer Investigational Site | Louisville | Kentucky | — | — |
| Pfizer Investigational Site | Baltimore | Maryland | — | — |
| Pfizer Investigational Site | Detroit | Michigan | — | — |
| Pfizer Investigational Site | The Bronx | New York | — | — |
| Pfizer Investigational Site | Cleveland | Ohio | — | — |
| Pfizer Investigational Site | Columbus | Ohio | — | — |
| Pfizer Investigational Site | Pittsburgh | Pennsylvania | — | — |
| Pfizer Investigational Site | Providence | Rhode Island | — | — |
| Pfizer Investigational Site | Norfolk | Virginia | — | — |
Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.
About this trial record page
- What this page shows
- Public field values for ClinicalTrials.gov record NCT00139685, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
- What this page does not do
- No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
- Where the data comes from
- Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
- Last refresh
- Last update posted Sep 24, 2008 · Synced Jun 26, 2026
Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.
Open the official record
The complete protocol, eligibility criteria, and contact information for NCT00139685 live on ClinicalTrials.gov.